8XJL image
Entry Detail
PDB ID:
8XJL
EMDB ID:
Title:
PGF2-alpha bound Prostaglandin F2-alpha receptor-Gq Protein Complex
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2023-12-21
Release Date:
2024-02-28
Method Details:
Experimental Method:
Resolution:
2.77 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Engineered miniGq
Chain IDs:A
Chain Length:246
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Chain IDs:B
Chain Length:376
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
Chain IDs:C
Chain Length:71
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Antibody fragment scFv16
Chain IDs:D (auth: E)
Chain Length:254
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Description:Fusion tag,Prostaglandin F2-alpha receptor,LgBiT
Chain IDs:E (auth: R)
Chain Length:588
Number of Molecules:1
Biological Source:synthetic construct, Homo sapiens
Ligand Molecules
Primary Citation
Structural basis for ligand recognition and activation of the prostanoid receptors.
Cell Rep 43 113893 113893 (2024)
PMID: 38446662 DOI: 10.1016/j.celrep.2024.113893

Abstact

Prostaglandin F2α (PGF2α) and thromboxane A2 (TXA2) are endogenous arachidonic acid metabolites, modulating diverse physiological processes including inflammation and cardiovascular homeostasis through activating PGF2α receptor (FP) and TXA2 receptor (TP). Ligands targeting FP and TP have demonstrated efficacy in treating conditions like glaucoma and cardiovascular diseases in humans, as well as reproductive-related diseases in animals. Here, we present five cryoelectron microscopy structures illustrating FP and TP in complex with Gq and bound to PGF2α (endogenous ligand), latanoprost acid (a clinical drug), and two other synthetic agonists. Combined with mutational and functional studies, these structures reveal not only structural features for the specific recognition of endogenous ligands and attainment of receptor selectivity of FP and TP but also the common mechanisms of receptor activation and Gq protein coupling. The findings may enrich our knowledge of ligand recognition and signal transduction of the prostanoid receptor family and facilitate rational ligand design toward these two receptors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures